Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells

Molecules

Volumn 15, Issue 8, 2010, Pages 5336-5353

  Szliszka, Ewelina ^a   Czuba, Zenon P ^a   Mazur, Bogdan ^a   Paradysz, Andrzej ^a   Krol, Wojciech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis; Chalcones and dihydrochalcones; Chemoprevention; Prostate cancer; TRAIL

Indexed keywords

CHALCONE DERIVATIVE; DIHYDROCHALCONE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CHALCONES; DRUG SYNERGISM; HUMANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77956116309     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15085336     Document Type: Article

References (38)

1. Dicarlo, G.; Mascolo, N.; Izzo, A.A.; Capasso, F. Flavonoids: Old and new aspects of class of natural therapeutic drugs. Life Sci. 1999, 65, 337-353.
2. Dimmock, J.R.; Elias, D.W.; Beazely, M.A.; Kandepu, N.M. Bioactivities of chalcones. Curr. Med. Chem. 1999, 6, 1125-1149.
3. Echeverria, C.; Santibanez, J.S.; Donoso-Tauda, O.; Escobar, C.A.; Ramirez-Tagle, R. Structural antitumoral activity relationships of synthetic chalcones. Int. J. Mol. Sci. 2009, 10, 221-231.
4. Shah, A.; Khan, A.M.; Qureshi, R.; Ansari, F.L.; Nazar, M.F.; Shah, S.S. Redox behavior of anticancer chalcone on a glassy carbon electrode and evaluation of its interaction parameters with DNA. Int. J. Mol. Sci. 2008, 9, 1424-1434.
5. Katsori, A.M.; Hadjipavlou-Latina, D. Chalcones in cancer: Understanding their role in terms of QSAR. Curr. Med. Chem. 2009, 16, 1062-1081.
6. Vogel, S.; Barbic, M.; Jurgenliemk, G.; Heilmann, J. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Eur. J. Med. Chem. 2010, 45, 2206-2213.
7. Heidenreich, A.; Aus, G.; Bolla, M.; Joniau, S.; Matveev, V.B.; Schmid, H.P.; Zattoni, F. European association of urology. EAU guidelines on prostate cancer. Eur. Urol. 2008, 53, 68-80.
8. Khan, N.; Adhami, V.M.; Mukhtar, H. Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr.-Related Cancer 2010, 17, 39-52.
9. Go, M.L.; Wu, X.; Liu, X.L. Chalcones: An update on cytotoxic and chemopreventive properties. Curr. Med. Chem. 2005, 12, 481-499.
10. Tomas-Barberan, F.A.; Clifford, M.N. Flavones, chalcones and dihydrochalcones - nature, occurrence and dietary burden. J. Sci. Food Agric. 2000, 80, 1073-1080.
11. Zhou, J.; Geng, G.; Batist, G.; Wu, J.H. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones. Bioorg. Med. Chem. Lett. 2009, 19, 1183-1186.
12. Lee, Y.M.; Lim, Y.; Choi, H.J.; Jung, J.I.; Chung, W.Y.; Park, J.H. Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin. J. Med. Food. 2009, 12, 8-14.
13. Fu, Y.; Hsieh, T.C.; Guo, J.; Kunicki, J.; Lee, M.Y.; Darzynkiewicz, Z.; Wu, J.M. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra) causes G2 and late-G1 arrests in androgen-independent PC3 prostate cancer cells. Biochem. Biophys. Res. Commun. 2004, 322, 263-270.
14. Desmulle, L.; Bellahcene, A.; Dhooge, W.; Comhaire, F.; Roelens, F.; Huvaere, K.; Heyerick, A.; Castronovo, V.; Dekeukeleire D. Antiproliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in prostate cancer cell lines. Phytomedicine 2006, 13, 732-734.
15. Jing, H.; Zhou, X.; Dong, X.; Cao, J.; Zhu, H.; Lou, J., Hu, Y., He, Q.; Yang, B. Abrogation of Akt signaling by isobavachalcone contributes to its anti-proliferative effects towards human cancer cells. Cancer Lett. 2010, 294, 167-177.
16. Almasan, A.; Ashkenazi, A. Apo2L/TRAIL: Apoptosis signaling, biology and potential for cancer therapy. Cytokine Growth Factor Rev. 2003, 14, 337-348.
17. Wu, G.S. TRAIL as a target in anti-cancer therapy. Cancer Lett. 2009, 285, 1-5.
18. Zhang, L.; Fang, B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 2005, 12, 228-237.
19. Horinaka, M.; Yoshida, T.; Shiraishi, T.; Nakata, S.; Wakada, M.; Sakai, T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol. Cancer Ther. 2006, 5, 945-951.
20. Shankar, S.; Chen, Q.; Siddiqui, I.; Sarva, K.; Srivastava, R.K. Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3,4',5- trihydroxystilbene): Molecular mechanisms and therapeutic potential. J. Mol. Signal. 2007, 2, 27-36.
21. Szliszka, E.; Czuba, Z.P.; Bronikowska, J.; Mertas, A.; Paradysz, A.; Krol, W. Ethanolic extract of propolis (EEP) augments TRAIL-induced apoptotic death in prostate cancer cells. Evid. Based Complement. Alternat. Med. 2009, doi:10.1093/ecam/nep180.
22. Szliszka, E.; Czuba, Z.P.; Mazur, B.; Sedek, L.; Paradysz, A.; Krol, W. Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int. J. Mol. Sci. 2010, 11, 1-13.
23. Shen, K.H.; Chang, J.K.; Hsu, Y.L.; Kuo, P.L. Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signaling in human bladder cancer cells. Basic Clin. Pharmacol. Toxicol. 2007, 101, 254-261.
24. Hsu, Y.L.; Kuo, P.L.; Tzeng, W.S.; Lin, C.C. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food Chem. Toxicol. 2006, 44, 704-713.
25. Chen, Y.L.; Kung, F.L.; Tsai, I.L.; Chou, T.H.; Chen, I.S.; Guh, J.H. Cryptocaryone, a natural dihydrochalcone, induces apoptosis in human androgen independent prostate cancer cells by death receptor clustering in lipid raft and nonraft compartments. J. Urol. 2010, 183, 2409-2418.
26. D'Archivio, M.; Santangelo, C.; Scazzocchio, B.; Vari, R.; Filesi, C.; Masella, R.; Giovannini, C. Modulatory effects of polyphenols on apoptosis induction: Relevance for cancer prevention. Int. J. Mol. Sci. 2008, 9, 213-228.
27. Han, X.; Shen, T.; Lou, H. Dietary polyphenols and their biological significance. Int. J. Mol. Sci. 2007, 8, 950-988.
28. Pereira, D.M.; Valentão, P.; Pereira, J.A.; Andrade, P.B. Phenolics: From chemistry to biology. Molecules 2009, 14, 2202-2211.
29. Jakóbisiak, M.; Lasek, W.; Goła̧b, J. Natural mechanisms protecting against cancer. Immunol. Lett. 2003, 90, 103-122.
30. Ferguson, L.R.; Philpott, M. Cancer prevention by dietary bioactive components that target the immune response. Curr. Cancer Drug Targets 2007, 7, 459-464.
31. Tang, Y., Li, X.; Liu, Z.; Simoneau, A.R.; Xie, J.; Zi, X. Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int. J. Cancer 2010, doi:10.1002/ijc.25210.
32. Yoshida, T.; Horinaka, M.; Takara, M.; Tsuchihashi, M.; Mukai, N.; Wakada, M.; Sakai, T. Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells. Environ. Health Prev. Med. 2008, 13, 281-287.
33. Kim, N. Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factorrelated apoptosis inducing ligand (TRAIL). Arch. Pharm. Res. 2008, 31, 1179-1186.
34. Szliszka, E.; Bronikowska, J.; Majcher, A.; Miszkiewicz, J.; Krol, W. Enhanced sensitivity of hormone-refractory prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated cytotoxicity by taxanes. CEJ Urol. 2009, 62, 29-34.
35. Szliszka, E.; Czuba, Z.P.; Domino, M.; Mazur, B.; Zydowicz, G.; Krol, W. Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 2009, 14, 738-754.
36. Szliszka, E.; Czuba, Z.P.; Jernas, K.; Krol, W. Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Int. J. Mol. Sci. 2008, 9, 56-64.
37. Bronikowska, J.; Szliszka, E.; Czuba, Z.P.; Zwolinski, D.; Szmydki, B.; Krol, W. The combination of TRAIL and isoflavones enhances apoptosis in cancer cells. Molecules 2010, 15, 2000-2015.
38. Cheah, Y.H.; Nordin, F.J.; Sarip, R.; Tee, T.T.; Azimahtol, H.L.; Sirat, H.M.; Rashid, B.A.; Abdullah N.R.; Ismail Z. Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231. Cancer Cell Int. 2009, 9, 1-12.